HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 323 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $18,217 | -27.4% | 477 | +8.2% | 0.00% | -33.3% |
| Q4 2022 | $25,093 | +47.6% | 441 | +0.2% | 0.00% | 0.0% |
| Q3 2022 | $17,000 | -10.5% | 440 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $19,000 | +11.8% | 434 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $17,000 | 0.0% | 434 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $17,000 | +70.0% | 434 | +83.1% | 0.00% | +50.0% |
| Q3 2021 | $10,000 | +150.0% | 237 | +189.0% | 0.00% | +100.0% |
| Q2 2021 | $4,000 | -33.3% | 82 | -44.6% | 0.00% | -66.7% |
| Q1 2021 | $6,000 | – | 148 | +7300.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 2 | -99.6% | 0.00% | -100.0% |
| Q1 2015 | $7,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |